Skip to main content

a FO (Fenofibrate 145 mg)

Pill with imprint a FO is White, Elliptical/Oval and has been identified as Fenofibrate 145 mg. It is supplied by Teva Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a FO

Fenofibrate

Imprint
a FO
Strength
145 mg
Color
White
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals
Inactive Ingredients
titanium dioxide, magnesium silicate, xanthan gum, docusate sodium, sucrose, sodium lauryl sulfate, lactose monohydrate, microcrystalline cellulose, magnesium stearate, hypromelloses, polyvinyl alcohol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-2060 (Discontinued) Teva Pharmaceuticals USA, Inc.
00074-6123 (Discontinued) Abbott Laboratories
68382-0230 (Discontinued) Zydus Pharmaceuticals (USA) Inc.
54868-5203 (Discontinued) Physicians Total Care Inc. (repackager)
54569-5750 A-S Medication Solutions, LLC (repackager)
55289-0973 PDRX Pharmaceuticals Inc. (repackager)
49999-0885 (Discontinued) Lake Erie Medical and Surgical Supply (repackager)
68071-0800 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "a FO"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.